CHM 0.00% 2.1¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-70

  1. 1,056 Posts.
    lightbulb Created with Sketch. 196
    PH Has a fan club from the glory days of free capital. Every pop star who is worth their salt experienced the downfall associated, especially when other people are loosing money. Before with IMU it was Hopper the God, now its Hopper the dog. The rise and fall, ebb and flow of sentiment will continue, but tell me, if you're focused on the delivery of the science, you wouldn't be surprised to see CHM at $1.70 rather than 1.7c at this stage, and the value gap is mostly attributable to sentiment IMO.

    I've seen this story on the RAC forum, where at 70c, Dr Tillet was copping much negativity. Now fast forward 3 months later, he is the messiah. Same when DXB triple raised at 8c, CEO was slagged. Now she's a Demi god! we could go on and on, but while sentiment is focused on a PH lynching, I'm focused on digging out any potential rocks while anyone is not looking to hopefully pick up a diamond.

    Crowds are crowds. Welcome to toilet bowl investing.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $6.09K 290K

Buyers (Bids)

No. Vol. Price($)
7 923541 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 176255 1
View Market Depth
Last trade - 10.02am 26/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.